#1 Clinical Trials Search in Europe

Desogestrel

This article examines the use of desogestrel, a progestin medication, in various clinical trials. Researchers are investigating desogestrel’s effectiveness in treating conditions like endometriosis, abnormal uterine bleeding, and its potential in ovarian stimulation protocols. The trials aim to evaluate desogestrel’s efficacy, safety, and compare it to other treatments.

Table of Contents

What is Desogestrel?

Desogestrel is a type of medication known as a progestogen, which is a synthetic form of the natural hormone progesterone. It is commonly used in birth control pills and other hormonal treatments. Desogestrel is also known by brand names such as Cerazette[1], Reclipsen[2], and Allurene[3].

Uses of Desogestrel

Desogestrel is used for various medical purposes, including:

  • Contraception: It is primarily used as a birth control method, either alone or in combination with other hormones[4].
  • Treatment of Endometriosis: Desogestrel may be used to manage pain associated with endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus[5].
  • Management of Abnormal Uterine Bleeding: It can help regulate menstrual cycles and reduce heavy bleeding in women with dysfunctional uterine bleeding[6].
  • Treatment of Endometriomas: Desogestrel may be used to treat endometriomas, which are cysts formed by endometrial tissue growing in the ovaries[7].
  • Management of Uterine Leiomyomas: It may help control symptoms associated with uterine fibroids, such as heavy bleeding[3].

How Desogestrel Works

Desogestrel works in several ways to achieve its effects:

  • Inhibiting Ovulation: It prevents the release of eggs from the ovaries[4].
  • Thickening Cervical Mucus: This makes it harder for sperm to reach the egg[4].
  • Thinning the Uterine Lining: This can help reduce heavy menstrual bleeding and make it less likely for a fertilized egg to implant[6].
  • Suppressing Endometrial Growth: In cases of endometriosis, it can help slow the growth of endometrial tissue[5].

Dosage and Administration

The dosage and administration of Desogestrel can vary depending on its use:

  • For Contraception: Typically, a dose of 75 micrograms is taken daily[4].
  • For Endometriosis: A higher dose of 150 micrograms daily may be prescribed[5].
  • For Abnormal Uterine Bleeding: It may be given cyclically, such as 150 micrograms daily for 10 days each month[6].

It’s important to take Desogestrel exactly as prescribed by your healthcare provider. The medication is usually taken orally, often at the same time each day to maintain consistent hormone levels.

Side Effects

Like all medications, Desogestrel can cause side effects. Common side effects may include:

  • Irregular menstrual bleeding or spotting
  • Headaches
  • Nausea
  • Breast tenderness
  • Mood changes
  • Weight gain

Most side effects are mild and often improve over time. However, if you experience severe or persistent side effects, you should consult your healthcare provider[4][7].

Ongoing Research

Researchers continue to study Desogestrel for various potential uses:

  • Congenital Central Hypoventilation Syndrome (CCHS): Also known as Ondine’s syndrome, this is a rare genetic disorder affecting breathing. Some studies are investigating whether Desogestrel can help improve breathing in patients with this condition[8][2].
  • Preoperative Treatment of Endometriomas: Research is being conducted to determine if Desogestrel can help reduce the size of endometriomas before surgery[7].
  • Improving Continuation Rates of Contraceptive Implants: Studies are exploring whether using Desogestrel before inserting a contraceptive implant can improve long-term use of the implant[4].

These ongoing studies may lead to new applications for Desogestrel in the future, potentially benefiting more patients with various conditions.

Aspect Details
Main Conditions Studied Endometriosis, Abnormal Uterine Bleeding, Uterine Leiomyomas, Ovarian Stimulation
Dosage Forms Oral tablets (0.075 mg, 0.15 mg)
Comparison Treatments Placebo, Medroxyprogesterone acetate, Goserelin, Dienogest
Primary Outcomes Measured Pain reduction, Bleeding control, Cyst diameter changes, Number of oocytes retrieved
Secondary Outcomes Side effects, Patient satisfaction, Hormonal changes, Occurrence of LH surge
Special Applications Use in ovarian stimulation protocols, Potential for flexible start dates in fertility treatments

FAQ

  • What is desogestrel? Desogestrel is a type of progestin medication used in birth control pills and for treating various gynecological conditions. It works by altering the lining of the uterus and cervical mucus to prevent pregnancy.
  • What conditions are being studied using desogestrel in clinical trials? Clinical trials are exploring desogestrel's potential in treating conditions such as endometriosis, abnormal uterine bleeding, uterine leiomyomas (fibroids), and its use in ovarian stimulation protocols for fertility treatments.
  • How is desogestrel being compared to other treatments in these trials? Desogestrel is being compared to placebos and other active treatments like medroxyprogesterone acetate, goserelin, and dienogest. Researchers are evaluating its efficacy, safety, and potential advantages over existing therapies.
  • What are some potential benefits of using desogestrel? Some potential benefits being studied include reduced pain in endometriosis, better control of abnormal uterine bleeding, and improved flexibility and comfort in ovarian stimulation protocols for egg donors.
  • Are there any side effects associated with desogestrel use in these trials? While specific side effects vary between trials, common side effects of desogestrel may include irregular bleeding, headaches, nausea, and mood changes. The trials are also monitoring for any unexpected adverse events.

Ongoing Clinical Trials on Desogestrel

  • Study Comparing Corifollitropin Alfa and Progestin Primed Ovarian Stimulation for Women with Subfertility Undergoing Elective Fertility Preservation or Genetic Testing

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium

  • Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System vs. Desogestrel Tablets for Preventing Pregnancy in Women

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Czechia Germany Hungary Lithuania Poland Romania +2

  • Study on the Effectiveness and Safety of AMY109 and Desogestrel for Women with Endometriosis

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Poland Romania

  • Study on Infertility: Comparing Corifollitropin Alfa and Follitropin Beta for Women Undergoing Elective Fertility Preservation

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Progestin: A synthetic form of progesterone, a female hormone, used in birth control pills and to treat various gynecological conditions.
  • Endometriosis: A condition where tissue similar to the lining of the uterus grows outside the uterus, often causing pain and fertility issues.
  • Dysfunctional Uterine Bleeding (DUB): Abnormal uterine bleeding that is not caused by structural abnormalities, often related to hormonal imbalances.
  • Leiomyoma: Also known as uterine fibroids, these are non-cancerous growths in the uterus that can cause heavy bleeding and pain.
  • Ovarian Stimulation: A process used in fertility treatments to encourage the ovaries to produce multiple eggs.
  • Bioequivalence: The property of two drugs having the same biological effect and availability in the body.
  • Luteinizing Hormone (LH): A hormone that plays a key role in ovulation and the menstrual cycle.
  • Gonadotropin-Releasing Hormone (GnRH): A hormone that regulates the production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
  • Follicle-Stimulating Hormone (FSH): A hormone that stimulates the growth of ovarian follicles in women and sperm production in men.
  • Vitrification: A fast-freezing technique used to preserve eggs or embryos in fertility treatments.

References

  1. https://clinicaltrials.gov/study/NCT02757287
  2. https://clinicaltrials.gov/study/NCT01500473
  3. https://clinicaltrials.gov/study/NCT01738724
  4. https://clinicaltrials.gov/study/NCT05174195
  5. https://clinicaltrials.gov/study/NCT01559480
  6. https://clinicaltrials.gov/study/NCT02103764
  7. https://clinicaltrials.gov/study/NCT04941833
  8. https://clinicaltrials.gov/study/NCT01243697